Where they practice, who they consult.
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Tianjin
- 35+ years in adult leukemia
- English, Mandarin
What they personally lead.
Training and recognition
Leads the Institute of Hematology, the only national-level hematology research institute in China; served as chair of the Chinese Society of Hematology Leukemia/Lymphoma Working Group; principal investigator on Chinese national AML cooperative trials; ranked #1 hematology institution in the Fudan China Hospital Rankings repeatedly across multiple years
What to expect
A reference center for newly diagnosed adult AML and MDS, especially for patients seeking comprehensive molecular profiling (FLT3, NPM1, IDH1/2, TP53) to guide induction and post-remission therapy.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Wang Jianxiang's background to other specialists in Tianjin. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.